Skip to main content

Table 1 Demographic and clinical characteristics of patients with multiple sclerosis according to cerebrospinal fluid proinflammatory cytokine content a

From: Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis

Characteristics

 

IL-1β

 

Total

+

P-value

Number

170

77

93

 

Gender (M/F)

62/108

27/50

35/58

0.75

Age (years)

36.3 ± 9.5

37.8 ± 10.1

35.1 ± 8.8

0.07

Disease duration (years)

10.5 ± 5.3

10.9 ± 5.9

10.2 ± 4.8

0.39

EDSS

2.2 ± 1.7

2.8 ± 1.9

1.7 ± 1.4

< 0.01

BREMS

0.34 ± 0.9

0.47 ± 1.0

0.23 ± 0.8

0.10

  1. a+, detectable; −, undetectable; BREMS, Bayesian Risk Estimate for Multiple Sclerosis; EDSS, Expanded Disability Status Scale; F, female; IL-1β, interleukin 1β; M, male. Data are mean ± SD.